Alliance for Multispecialty Research, LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease2 trials
• Obesity2 trials
• Type 2 diabetes2 trials
• Coronary artery disease1 trial
• Gout1 trial
• Heart failure1 trial
• Peripheral artery disease1 trial
• Stroke1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• LG Chem1 trial

Running trials

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

  NCT05803421· Phase 3· Eli Lilly and Company· Source

• Completed

  Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

  NCT05586971· Phase 3· LG Chem· Source